Treatment reduction for children and young adults with low-risk acute lymphoblastic leukaemia defined by minimal residual disease (UKALL 2003): a randomised controlled trial. (2013)

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/S1470-2045(12)70600-9

PubMed Identifier: 23395119

Publication URI: http://europepmc.org/abstract/MED/23395119

Type: Journal Article/Review

Volume: 14

Parent Publication: The Lancet. Oncology

Issue: 3

ISSN: 1470-2045